What does Spruce Biosciences, Inc. do?
Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo…
What is Spruce Biosciences, Inc.'s P/E and P/B ratio?
Spruce Biosciences, Inc. has a P/E ratio of -1.2 and a P/B ratio of 1.55.
What is Spruce Biosciences, Inc.'s debt-to-equity ratio?
Spruce Biosciences, Inc. has a debt-to-equity ratio of 0.09.
How much does Spruce Biosciences, Inc. owe compared with what it owns?
Spruce Biosciences, Inc. owes $0.19 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Spruce Biosciences, Inc.'s Positivity rank?
Spruce Biosciences, Inc. is ranked #2,366 of 6,775 companies globally and #713 of 4,000 in United States on PositoAI, with a Positivity Score of 21,637.
Does Spruce Biosciences, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Spruce Biosciences, Inc..
Where can I read the latest news about Spruce Biosciences, Inc.?
Recent headlines about Spruce Biosciences, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Spruce Biosciences, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Spruce Biosciences, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.